NCT04749394 2022-08-16A Study of Camrelizumab Plus Apatinib as Consolidation Therapy in Non-Small Cell Lung Cancer Patients Treated With ChemoradiotherapyChineseAMSPhase 2 Unknown42 enrolled
NCT04683198 2020-12-24Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLCChineseAMSPhase 2 Unknown69 enrolled
NCT02995187 2017-09-07Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC)ChineseAMSPhase 2 Unknown25 enrolled